Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/10/31 17:57:28」(JST)

wiki en

Ethynodiol diacetate (INN; sold as Continuin, Femulen, Luteonorm, Luto-Metrodiol, and Metrodiol), or ethynodiol diacetate (USAN, BAN), is a steroidal progestin which is used as a hormonal contraceptive.^[1]^[2] Relative to other 19-nortestosterone derivatives, it has relatively little or no potency as an androgen,^[3]^[4] and also unlike most progestins in general, has significant estrogenic effects.^[5]^[3]

References[edit]

^ F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1454. ISBN 978-0-412-46630-4. Retrieved 12 May 2012.
^ Index Nominum 2000: International Drug Directory. Taylor & Francis US. 2000. p. 422. ISBN 978-3-88763-075-1. Retrieved 30 May 2012.
^ ^a ^b Kenneth L. Becker (24 April 2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. p. 1004. ISBN 978-0-7817-1750-2. Retrieved 30 May 2012.
^ Chaudhuri (1 January 2007). Practice Of Fertility Control: A Comprehensive Manual (7Th Edition). Elsevier India. p. 122. ISBN 978-81-312-1150-2. Retrieved 30 May 2012.
^ Allan H. Goroll; Albert G. Mulley (27 January 2009). Primary Care Medicine: Office Evaluation and Management of the Adult Patient. Lippincott Williams & Wilkins. p. 876. ISBN 978-0-7817-7513-7. Retrieved 30 May 2012.

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

This article about a steroid is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 思春期における多嚢胞性卵巣症候群の治療 treatment of polycystic ovary syndrome in adolescents

English Journal

Relationship between use of different oral contraceptive formulations and breast cancer risk among young women.

E B, D B, W B, K M, S R, C L.AbstractPURPOSE: Prior studies suggest that recent oral contraceptive (OC) use is associated with a modest increased risk of breast cancer among young women. However, the majority of these reports have relied on self-reported use and have not characterized risks associated with newer OC formulations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.Cancer Epidemiol Biomarkers Prev.2012 Mar;21(3):566. Epub 2012 Feb 15.
PURPOSE: Prior studies suggest that recent oral contraceptive (OC) use is associated with a modest increased risk of breast cancer among young women. However, the majority of these reports have relied on self-reported use and have not characterized risks associated with newer OC formulations.METHODS
PMID 22337552

Japanese Journal

小用量のEthynodiol diacetateとEthinyl estradiolの合剤による経口避妊

東山秀声,岡田弘二
産婦人科の進歩 34(4), p207-217, 1982-07
NAID 40001496581

Related Pictures

★リンクテーブル★

リンク元	「エチノジオール」「酢酸エチノジオール」「二酢酸エチノジオール」
拡張検索	「ethynodiol diacetate containing combination」
関連記事	「diacetate」

「エチノジオール」

Etynodiol diacetate
Systematic (IUPAC) name
	(3β,17β)-17-ethynylestr-4-ene-3,17-diyl diacetate
Clinical data
Pregnancy cat.	?
Legal status	℞ Prescription only
Routes	Oral
Identifiers
CAS number	297-76-7; 8056-92-6
ATC code	G03DC06; G03AA01 G03FA06 (with an estrogen)
PubChem	CID 92709270
DrugBank	DB00823
ChemSpider	8913
Chemical data
Formula	C24H32O4
Mol. mass	384.509 g/mol
	SMILES O=C(O[C@@H]4/C=C3\[C@@H]([C@H]2CC[C@]1([C@@H](CC[C@]1(C#C)OC(=O)C)[C@@H]2CC3)C)CC4)C;
	InChI InChI=1S/C24H32O4/c1-5-24(28-16(3)26)13-11-22-21-8-6-17-14-18(27-15(2)25)7-9-19(17)20(21)10-12-23(22,24)4/h1,14,18-22H,6-13H2,2-4H3/t18-,19-,20+,21+,22-,23-,24-/m0/s1; Key:ONKUMRGIYFNPJW-KIEAKMPYSA-N ;